Large-scale testing (Phase 3)Study completedNCT04841577
What this trial is testing
A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 60 Years and Above
Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 976